Companion Diagnostics Market Size

Jul 18, 2025

0 likes | 5 Vues

Télécharger la présentation

Companion Diagnostics Market Size

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Companion Diagnostics Market: Global Industry Analysis and F

201 views • 4 slides

Global Companion Diagnostics Market Analysis to 2020

Companion diagnostics refer to the test or measurement which provides essential information about the patient’s genetic and genomic characteristics to the physicians for making treatment decision. This information is important for the safe and effective use of corresponding drugs and therapies in the treatment. Rise in awareness about personalized medicines, technological advancement and government initiatives are some of the major factors which are driving the companion diagnostics market.

208 views • 4 slides

Companion Diagnostics Market Boosted Myriad’s Deal With BeiGene

The Companion Diagnostics Market deals with the development of tests to comprehend which patient can be profited from a specific medication or what dose ought to be recommended in light of a patient's clinical conclusion, which gives the confirmation of required effective and innocuous utilization of a proportional medication or natural item to treat the restorative condition. Such medicinal instruments, produced by companion diagnostic companies, guide specialists to choose which treatment and measurements ought to be given to patients and are customized to their needs.

172 views • 7 slides

Companion Diagnostics Market Size, Share, Drivers & Trends Analysis to 2022

The report studies Companion Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer.

64 views • 3 slides

Companion Diagnostics Market Size, Analysis and Forecast till 2026

Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy. Companion diagnostic is one such emerging field for target biomarker identification reducing clinical trial cost and time to market the product.

55 views • 3 slides

Companion Diagnostics Market Share

Companion diagnostics development has majorly been focused at the treatment of the various types of cancers, their indications, and their indication subtypes. The following figure depicts the global companion diagnostics market according to the various types of cancer indications. The considered indications include breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, stomach cancer, and other cancer types.

120 views • 10 slides

Companion Diagnostics Market, By Technology

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography.

82 views • 6 slides

Global Companion Diagnostics Market

Global Companion Diagnostics Market was valued US$ 2.68 Bn in 2017 and is expected to reach US$ 10.76 Bn by 2026, at a CAGR of 18.98 % during a forecast period.

68 views • 5 slides

Companion Diagnostics Market | Trends & forecast | 2018-2025

This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.

96 views • 8 slides

Global Companion Diagnostics market | Inkwood Research

The global companion diagnostics market was valued at $2608 million in 2017 & is estimated to generate net revenue of approximately $11980 million by 2026, growing at a CAGR of 18.45%. Read more: https://www.inkwoodresearch.com/reports/companion-diagnostics-market/

138 views • 12 slides

Companion Diagnostics Market

The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period. A companion diagnostics test is done to understand which patient can gain benefits from a specific drug or decide upon the kind of dosage that should be prescribed. All of this, on the basis of a patients clinical diagnosis, which offers required evidence for the successful and harmless utilization of an equivalent biological or drug product to treat the medical issue. These can also be referred to as medical instruments that help doctors in electing which dosage or treatment is sufficient for patients and suits to their necessity. The growth of research and development activities in the genetic sciences and biomarkers leads to new drug development mechanisms, dominated by companion diagnostics in the personalized medicine phase. Moreover, the development and usage of companion diagnostics have considerably improved the knowledge of the molecular causes of illnesses, the identification of many biomarkers and the development of targeted treatment. Full Report: https://www.kbvresearch.com/companion-diagnostics-market/

108 views • 9 slides

Companion Diagnostics Market 2020 Growth Analysis

The growth of the companion diagnostics market is primarily driven by rising prevalence of cancer and growing trends towards personalized medicine. Cancer is the second leading cause mortalities in 2018, with continuous rise in the number of cancer patient across the globe, as per the report published by WHO.

60 views • 3 slides

Companion Diagnostics Market

62 views • 4 slides

Companion Animal Diagnostics Market Size, Industry Trends, Share and Forecast 2019-2025

The global companion animal diagnostics market is expected to show considerable growth during the forecast period owing to the rising adoption of companion animals and need to prevent them from zoonotic disorders. Data from the American Pet Products Association shows that the number of households with a companion animal has increased from 79.7 million to 84.6 million from the year 2016 to 2018.

53 views • 4 slides

Companion Diagnostics Market Global Outlook 2020 to 2030

The Global Companion Diagnostics Market size was valued at USD 1.96 billion in 2019 and is predicted to reach USD 9.02 billion by 2030, with a CAGR of 14.8% from 2020-2030.

32 views • 2 slides

Global Companion Diagnostics Market Size, Status and Forecast 2020-2026

Companion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource.

95 views • 8 slides

Global Companion Diagnostics Market Size, Industry Trends, Share and Forecast 2020-2026

The global companion diagnostics market is growing at a significant CAGR of around 12.8% during the forecast period (2020-2026). Companion diagnostics is referred to as in-vitro diagnostic device or an imaging tool that is used as a companion to a certain class of a therapeutic drug, to determine its relevancy to a patient.

65 views • 5 slides

Industrial Outlook of Companion Diagnostics Market

The companion diagnostics (CDx) market is projected to grow at a CAGR of 13.14% to reach US$8.974 billion by 2024, from US$4.278 billion in 2018. The growing prevalence of chronic disorders and the improving regulatory framework for supporting drug-diagnostic co-development models are driving the growth of the global companion diagnostics market.

73 views • 5 slides

Companion Diagnostics Market Growth Analysis 2023

The latest report by Precision Business Insights, titled u201cCompanion Diagnostics Marketu201d covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

73 views • 5 slides

Global Cancer Diagnostics Market Size

Cancer Diagnostics Market size was valued at USD 160.5 billion in 2021 and is poised to grow from USD 171.5 billion in 2022 to USD 276.8 billion by 2030, growing at a CAGR of 6.89% in the forecast period (2023-2030).

66 views • 5 slides

Global Companion Diagnostics Market

Companion Diagnostics Market was valued at USD 4.18 billion in 2021 and it is expected to reach a value of USD 15.13 billion by 2028, at a CAGR of 12.90% over the forecast period (2022-2028).

43 views • 3 slides

Companion Animal Diagnostics Market

Companion Animal Diagnostics Market by Manufacturers, Regions, Type and Application Forecast to 2032

16 views • 7 slides

More Related